Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Suncor Energy Inc. (SU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Suncor Energy Inc. — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Suncor Energy Inc. trades at $75.97 (market cap $87.48B). The key difference: Suncor Energy Inc. is far larger — about 9.9× Kymera Therapeutics Inc. Common Stock's market cap, and Suncor Energy Inc. pays a 2.26% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Suncor Energy Inc. for 57 Days on average.
| KYMR | SU | |
|---|---|---|
Market Cap | $8.87B | $87.48B |
Volume | 779,107 | 3,692,639 |
Sector | Health | Energy |
52-Week High | $127.31 | $75.89 |
52-Week Low | $55.80 | $38.17 |
Typical Hold Time | 0 Days | 57 Days |
Enterprise Value | $8.26B | $94.00B |
Dividend Yield | — | 2.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Suncor Energy (SU) trades at $75.89, up 3.24% with strong technical momentum and bullish moving average signals. The stock shows robust fundamentals with a P/E of 14.32, net income margin of 14.7%, and consistent cash flow generation. Recent news highlights strategic asset divestitures and leadership transitions, while analyst consensus remains strongly positive with 74% buy ratings.
Outlook remains favorable given SU's integrated oil sands operations and aggressive shareholder returns through dividends and buybacks. Key risks include commodity price volatility and operational challenges, but the company's strong balance sheet and improving debt metrics provide stability. Current valuation appears reasonable relative to earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →
